vaccine on Friday. Following a thorough safety review, including two meetings of the CDC’s Advisory Committee on Immunization Practices, the US Food and Drug Administration and the US Centers for Disease Control and Prevention have determined that the recommended pause regarding the use of the Johnson & Johnson (Janssen) COVID-19 Vaccine in the US should be lifted and use of the vaccine should resume, the agencies said in a joint statement.The two agencies said that the use of the Janssen COVID-19 Vaccine should be resumed in the United States.
The FDA and CDC have confidence that this vaccine is safe and effective in preventing COVID-19. The FDA has determined that the available data show that the vaccine’s known and potential benefits.